Free Design Audit Available - Click Here for Details

FDA clears computer-assisted thrombectomy system from Penumbra

Penumbra (NYSE:PEN) announced today that it received FDA clearance for and began the launch of its Lightning Flash 2.0 CAVT system.

Lightning Flash 2.0 represents the next generation of the company’s computer-assisted vacuum thrombectomy (CAVT) technology. It removes the venous thrombus to treat pulmonary emboli (PE).

The system features Lightning Flash algorithms designed for increased speed and sensitivity to thrombus and blood flow. Combined with Penumbra’s novel catheter technology, the new advancements help to better navigate the patient’s anatomy. This helps to deliver high power for clot removal with possible minimal blood loss.

Dr. James F. Benenati, chief medical officer at Penumbra said the company already has positive feedback from its initial launch. Early reports showed improved procedure time through shortened aspiration time, plus reductions in blood removed during aspiration.

Sign up for Blog Updates